home / stock / rcel / rcel news


RCEL News and Press, Avita Medical Inc. From 10/28/25

Stock Information

Company Name: Avita Medical Inc.
Stock Symbol: RCEL
Market: NASDAQ
Website: avitamedical.com

Menu

RCEL RCEL Quote RCEL Short RCEL News RCEL Articles RCEL Message Board
Get RCEL Alerts

News, Short Squeeze, Breakout and More Instantly...

RCEL - AVITA Medical Welcomes Support for RECELL® in Burns in Australia

Australia’s Medical Services Advisory Committee (MSAC) recognizes RECELL ® as safe and effective, with benefits in healing, donor site sparing, and reduced hospital stays VALENCIA, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: ...

RCEL - US Companies Moving the Markets, Morning edition
Fri, Oct 17, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Rani Therapeutics Holdings Inc. (RANI) rose 158.0% to $1.215 on volume of 150,083,425 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 3.9% to $4.175 on volume of 72,025,447 shares Bitfarms Ltd. (BITF) fell 8.5% to $4.83 o...

RCEL - RCEL Price Target Alert: $4.00. Issued by Lake Street

2025-10-17 08:23:05 ET Frank Takkinen from Lake Street issued a price target of $4.00 for RCEL on 2025-10-17 11:38:45. The adjusted price target was set to $4.00. At the time of the announcement, RCEL was trading at $5.38. The overall price target consensus is at $4.00 w...

RCEL - AVITA Medical appoints Cary Vance as interim CEO

2025-10-17 02:09:37 ET More on AVITA Medical AVITA Medical: Reimbursement Reset And Breakeven Path By 2026 AVITA Medical, Inc. (RCEL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) AVITA Medical: Green Shoots Peaking Out From Hard Cl...

RCEL - AVITA Medical Announces CEO Transition

Board Chairman Cary Vance appointed Interim CEO Board member Jan Stern Reed appointed Lead Independent Director Third quarter 2025 preliminary revenue expected to be approximately $17 million VALENCIA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. ...

RCEL - CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds

Hospitals may receive up to $4,875 in added reimbursement when using RECELL to treat non-burn full-thickness acute wounds resulting from trauma or surgery Effective October 1, the add-on payment eases financial barriers, supporting broader use of RECELL VALENCIA, Calif., O...

RCEL - AVITA Medical: Reimbursement Reset And Breakeven Path By 2026

2025-09-18 07:30:24 ET Read the full article on Seeking Alpha For further details see: AVITA Medical: Reimbursement Reset And Breakeven Path By 2026

RCEL - US Companies Moving the Markets, Evening edition
Mon, Sep 15, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States AtlasClear Holdings Inc. (ATCH) rose 153.8% to $0.99 on volume of 489,466,019 shares Opendoor Technologies Inc (OPEN) rose 4.7% to $9.495 on volume of 324,115,575 shares Direxion Daily TSLA Bull 2X Shares (TSLL) rose 6.9% to $18.21 on v...

RCEL - Avita Medical stock jumps 10% after securing CE Mark for RECELL GO

2025-09-15 05:30:16 ET More on AVITA Medical AVITA Medical, Inc. (RCEL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) AVITA Medical: Green Shoots Peaking Out From Hard Clay AVITA Medical, Inc. 2025 Q2 - Results - Earnings Call Prese...

RCEL - AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe

VALENCIA, Calif., Sept. 14, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical”, or the “Company”), a leading therapeutic acute wound care company, today announced it has received the CE Mark under the European Union Medical D...

Previous 10 Next 10